Delivery Order SPE2DB25D3306-SPE2DB26FUALQ
- Not listed
- The Defense Logistics Agency awarded a $17,333.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for JADENU 360 mg tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The work will be performed at AmerisourceBergen's...
- AmerisourceBergen Drug Corp received a $37,524.35 delivery order from the Defense Logistics Agency (DLA) on July 17, 2025, for the supply of Jadenu 360 mg tablets (30-count units). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Jadenu is an iron chelation therapy medication used to treat chronic iron overload, a condition common...
- The Defense Logistics Agency awarded a $40,176.29 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of JADENU 360 mg tablets (30-count packages). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,490.00 by the Defense Logistics Agency's Medical Supply Chain for the supply of Jadenu 360 mg tablets (30-count units). The award, issued on June 2, 2025, with a completion date of June 3, 2025, represents a firm fixed-price contract with no set-aside designation, indicating competitive award. The point of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,062.11 to AmerisourceBergen Drug Corp for the supply of JADENU 360 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery at its corporate office...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $28,728.06, is for the supply of JADENU 360 MG TABLET 30S, a specialty pharmaceutical product. The award has an ultimate completion date of October 16, 2024 and was made on October 15, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- The Defense Logistics Agency Troop Support Medical awarded a $22,779 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562164284 Jadenu 360 mg tablets. The order is for 30 tablets to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 14, 2023. No additional details were provided regarding the original solicitation or whether this order is associated with any particular contracting vehicle. The award was made without any set aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 29, 2025, for the supply of Jadenu 360 mg tablets (30-count) valued at $36,535.05. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, was competitively awarded with no set-aside designation and is funded by the Defense Logistics Agency's Medical Supply Chain division. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply JADENU 360 MG TABLET 30S. The $147,112.99 delivery order is not associated with a set-aside program and was awarded on August 31, 2022, with a completion date of September 1, 2022. Amerisourcebergen Drug Corp provides pharmaceutical products and services as a prime contractor to U.S. government agencies, primarily...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $42,178.14 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 4561654541 JADENU 360 MG TABLET 30S to an agency location in Conshohocken, Pennsylvania. Performance is required from July 31 through August 1, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, this order supports the Defense Logistics Agency's mission to provide...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUALQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $84,982.81 to AmerisourceBergen Drug Corp for the supply of Jadenu 360 mg tablets (30-count units) on October 15, 2025, with an ultimate completion date of October 16, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills this order under its broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The delivery order is part of AmerisourceBergen's comprehensive pharmaceutical support vehicle that enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. Jadenu is a chelation therapy medication used in the treatment of iron overload, reflecting the company's role in delivering specialized pharmaceutical products across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The contractor's consistent receipt of competitively awarded delivery orders across diverse medical product categories demonstrates its established capability to meet federal procurement requirements and support military readiness through reliable pharmaceutical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $85.0k | 10/15/25 |